Seguir
Ingrid Anderson
Ingrid Anderson
Vanderbilt-Ingram Cancer Center
Dirección de correo verificada de vanderbilt.edu
Título
Citado por
Citado por
Año
Elimination of a genetic correlation between the sexes via artificial correlational selection
LF Delph, JC Steven, IA Anderson, CR Herlihy, ED Brodie III
Evolution 65 (10), 2872-2880, 2011
862011
Beyond histology: translating tumor genotypes into clinically effective targeted therapies
CB Meador, CM Micheel, MA Levy, CM Lovly, L Horn, JL Warner, ...
Clinical Cancer Research 20 (9), 2264-2275, 2014
782014
Relaxed pollinator‐mediated selection weakens floral integration in self‐compatible taxa of Leavenworthia (Brassicaceae)
IA Anderson, JW Busch
American Journal of Botany 93 (6), 860-867, 2006
632006
The path (way) less traveled: a pathway-oriented approach to providing information about precision cancer medicine on my cancer genome
AD Taylor, CM Micheel, IA Anderson, MA Levy, CM Lovly
Translational oncology 9 (2), 163-165, 2016
322016
Guiding oncology patients through the maze of precision medicine
NB Giuse, SV Kusnoor, TY Koonce, HM Naylor, SC Chen, ...
Journal of health communication 21 (sup1), 5-17, 2016
322016
My cancer genome: evaluating an educational model to introduce patients and caregivers to precision medicine information
SV Kusnoor, TY Koonce, MA Levy, CM Lovly, HM Naylor, IA Anderson, ...
AMIA Summits on Translational Science Proceedings 2016, 112, 2016
282016
Internet-based assessment of oncology health care professional learning style and optimization of materials for web-based learning: controlled trial with concealed allocation
CM Micheel, IA Anderson, P Lee, SC Chen, K Justiss, NB Giuse, F Ye, ...
Journal of medical Internet research 19 (7), e265, 2017
162017
My cancer genome: coevolution of precision oncology and a molecular oncology knowledgebase
ME Holt, KF Mittendorf, M LeNoue-Newton, NM Jain, I Anderson, ...
JCO Clinical Cancer Informatics 5, 995-1004, 2021
142021
Preliminary results from a phase II study of the combination of pevonedistat and azacitidine in the treatment of MDS and MDS/MPN after failure of DNA methyltransferase inhibition
TK Moyo, JM Watts, BS Skikne, JH Mendler, VM Klimek, SC Chen, R Fan, ...
Blood 134, 4236, 2019
122019
PI3K inhibition restores and amplifies response to ruxolitinib in patients with myelofibrosis
TK Moyo, A Kishtagari, MT Villaume, B McMahon, SR Mohan, ...
Clinical Cancer Research 29 (13), 2375-2384, 2023
32023
Rapid reversal of a potentially constraining genetic covariance between leaf and flower traits in Silene latifolia
JC Steven, IA Anderson, ED Brodie III, LF Delph
Ecology and Evolution 10 (1), 569-578, 2020
32020
Topic: AS08-Treatment/AS08f-Clinical trials–Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT …
J Watts, B Smith, T Bradley, B Skikne, J Mendler, V Klimek, A Thomassen, ...
Leukemia Research 128, 107272, 2023
2023
11. MCG 2.0: A highly curated, scalable precision cancer medicine resource
M Holt, C Micheel, I Anderson, M LeNoue-Newton, N Jain, C Miller, ...
Cancer Genetics 233, S5, 2019
2019
49. Assessment of breast cancer trial landscape utilizing a structured clinical trial knowledgebase
N Jain, M LeNoue-Newton, I Anderson, C Micheel, M Levy
Cancer Genetics 226, 54, 2018
2018
27. Biomarker driven clinical trial curation and search
M LeNoue-Newton, N Jain, I Anderson, C Micheel, M Levy
Cancer Genetics 226, 46, 2018
2018
7. Data and knowledge sharing to improve patient care: The VICC and MCG experience
I Anderson, N Jain, M LeNoue-Newton, C Micheel, M Levy
Cancer Genetics 226, 38-39, 2018
2018
The role of developmental constraint in mating-system evolution in Leavenworthia: A quantitative genetic analysis
IA Anderson
Indiana University, 2005
2005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–17